BCAB
BCAB
NASDAQ · Biotechnology

Bioatla Inc

$0.21
+0.02 (+10.78%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.16M 1.98M 2.25M
Net Income -609,365 -497,914 -589,745
EPS
Profit Margin -28.2% -25.1% -26.2%
Rev Growth +2.0% +14.6% +17.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.12M 5.92M 6.90M
Total Equity 9.93M 9.80M 9.64M
D/E Ratio 0.62 0.60 0.72
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -937,252 -843,277 -1,004,481
Free Cash Flow -606,690 -515,846 -697,858